vascular
Peripheral Arterial Disease
ABPI, claudication management, and critical limb-threatening ischaemia pathway
Source: NICE NG19 2012 / ESVS 2017
Step 1 of ~8
info
PAD Assessment
History: claudication distance, rest pain. Examination: pulses, capillary refill. ABPI: <0.9 = PAD; <0.5 = severe; >1.4 = calcified (measure toe pressure).
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Naftidrofuryl Oxalate · 5-HT2 Receptor Antagonist — Peripheral Arterial Disease (Intermittent Claudication)
- Alteplase (Peripheral Arterial / DVT Use) · Thrombolytic — Catheter-Directed Thrombolysis / Peripheral Arterial Occlusion
- Amlodipine · Dihydropyridine Calcium Channel Blocker — Raynaud's / Peripheral Vascular Disease / Hypertension
- Streptokinase · Thrombolytic — Peripheral Arterial Occlusion / DVT (Historical)
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
Decision support only. Always apply local guidelines and clinical judgement.